HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats.

AbstractOBJECTIVE:
The clinical usefulness of doxorubicin (adriamycin, ADR) is restricted by the risk of developing congestive heart failure. Probucol has been reported to completely prevent ADR cardiomyopathy without interfering with its antitumor effects. The current study investigated the effects of ADR and probucol on antioxidant enzyme gene expression during adriamycin-induced cardiomyopathy in a rat model.
METHODS:
The mRNA abundance by Northern and immunoreactive protein levels by Western blotting of myocardial antioxidant enzymes, glutathione peroxidase (GSHPx), manganese superoxide dismutase (MnSOD) and catalase (CAT) were examined in relation to the enzyme activities in hemodynamically assessed control and treated animals.
RESULTS:
At 3 weeks post-treatment duration, ADR caused heart failure which was prevented by probucol. MnSOD mRNA abundance as well as protein levels were depressed by ADR treatment by 45% and 20%, respectively, and this change was prevented by probucol. However, the mRNA and protein levels of GSHPx and CAT were not significantly changed by ADR or probucol. ADR had no effect on SOD activity but this enzyme activity was increased by probucol and probucol plus ADR. GSHPx enzyme activity was decreased and oxidative stress as indicated by TBARS was increased by ADR and these changes were also modulated by probucol.
CONCLUSION:
An increase in oxidative stress, GSHPx inactivation and MnSOD downregulation during ADR cardiomyopathy were prevented by probucol treatment.
AuthorsT Li, I Danelisen, A Belló-Klein, P K Singal
JournalCardiovascular research (Cardiovasc Res) Vol. 46 Issue 3 Pg. 523-30 (Jun 2000) ISSN: 0008-6363 [Print] England
PMID10912462 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticholesteremic Agents
  • Antineoplastic Agents
  • Antioxidants
  • RNA, Messenger
  • Thiobarbituric Acid Reactive Substances
  • Doxorubicin
  • Catalase
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Probucol
Topics
  • Analysis of Variance
  • Animals
  • Anticholesteremic Agents (therapeutic use)
  • Antineoplastic Agents
  • Antioxidants (metabolism)
  • Blotting, Northern
  • Blotting, Western
  • Catalase (genetics)
  • Doxorubicin
  • Glutathione Peroxidase (metabolism)
  • Heart Failure (chemically induced, prevention & control)
  • Lipid Peroxidation
  • Male
  • Probucol (therapeutic use)
  • RNA, Messenger (analysis)
  • Rats
  • Rats, Sprague-Dawley
  • Superoxide Dismutase (genetics)
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Ventricular Pressure (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: